Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 16,533 shares at $49.92 ($843K) on 2021-08-02, disclosed to the SEC on 2021-08-03.
Open-market sale of $843k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.92 | 3,139 | $157K | 18.6% |
| 2 | $49.92 | 3,139 | $157K | 18.6% |
| 3 | $51.35 | 3,728 | $191K | 22.7% |
| 4 | $51.35 | 3,728 | $191K | 22.7% |
| 5 | $52.41 | 1,246 | $65K | 7.7% |
| 6 | $52.41 | 1,246 |
| $65K |
| 7.7% |
| 7 | $53.32 | 307 | $16K | 1.9% |
| Total | $51.00 avg | 16,533 | $843K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |